ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ELIDEL
Miscellaneous dermatological conditions
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ELIDEL Rx

Generic Name and Formulations:
Pimecrolimus 1%; crm.

Company:
Valeant Pharmaceuticals, Inc

Therapeutic Use:

Indications for ELIDEL:

Second-line therapy: for short-term and non-continuous chronic treatment of mild-to-moderate atopic dermatitis in non-immunocompromised patients when other topical therapies are inadvisable or ineffective.

Adults and Children:

<2yrs: not recommended. ≥2yrs: apply to affected area(s) twice daily. Do not occlude.

Warnings/Precautions:

Clear infections at treatment site before starting. Netherton's syndrome, generalized erythroderma, malignant or pre-malignant skin conditions: not recommended. Varicella zoster. Eczema herpeticum. Herpes simplex. Consider discontinuing if lymphadenopathy of unknown etiology or acute infectious mononucleosis occurs. Consider discontinuing until warts clear if skin papillomas worsen or are unresponsive. Avoid sun, UV light. Reevaluate if no improvement after 6 weeks. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Caution with CYP3A inhibitors in widespread and/or erythrodermic disease.

Pharmacological Class:

Immunomodulator.

Adverse Reactions:

Local reactions (eg, burning), nasopharyngitis, pyrexia, cough, headache, others; rare: malignancy (eg, skin, lymphoma).

How Supplied:

Crm—30g, 60g, 100g

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs